<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38188329</PMID><DateRevised><Year>2024</Year><Month>01</Month><Day>09</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Factors associated with long COVID syndrome in a Colombian cohort.</ArticleTitle><Pagination><StartPage>1325616</StartPage><MedlinePgn>1325616</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1325616</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2023.1325616</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">After acute phase of SARS-CoV-2 infection, some patients persist with clinical symptoms, a phenomenon known as Long COVID syndrome. It is necessary to understand the factors associated with the persistence of these symptoms to develop individualized preventive approaches and effectively address this challenge.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To determine the factors associated with the persistence of symptoms six months after COVID-19 infection.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">A ambidirectional cohort, single-center study, that included individuals previously diagnosed with COVID-19 by real-time polymerase chain reaction (PCR) positive test, who were followed for a period of six months. Univariate, bivariate and a multivariate binomial regression model were performed to determine risk factors associated with the persistence of COVID-19 symptoms at the six months of follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The prevalence of long COVID syndrome was 47%. Age demonstrated no significant association with Long COVID (RR 0.999 [95% CI 0.996-1.002]); however, female sex (RR 1.148 [95% CI 1.038-1.268]), requirement of mechanical ventilation (RR 1.278 [95% CI 1.050-1.555]), presence of Chronic Obstructive Pulmonary Disease (COPD) (RR 1.340 [95% CI 1.104-1.626]), Rheumatic Disease (RR 1.259 [95% CI 1.055-1.504]) and the Hospitalization Type: General Hospitalization (RR 1.247 [95% CI 1.090-1.427]) and ICU Hospitalization (RR 1.490 [95% CI 1.221-1.818]) were significantly associated with the persistence of symptoms at the six month of follow-up.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Female sex, presence of COPD, rheumatic disease, hospitalization type and requirement of mechanical ventilation during index infection were identified as significant risk factors for the diagnosis of Long COVID. These findings emphasize the importance of addressing Long COVID syndrome in terms of prevention and management, taking these risk factors into consideration.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Mart&#xed;nez-Ayala, Proa&#xf1;os, Cala-Duran, Lora-Mantilla, C&#xe1;ceres-Ram&#xed;rez, Villabona-Fl&#xf3;rez and Camacho-L&#xf3;pez.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mart&#xed;nez-Ayala</LastName><ForeName>Mar&#xed;a Camila</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>School of Medicine, Universidad de La Sabana, Ch&#xed;a, Colombia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Directorate of Research, Development and Technological Innovation, Ophthalmological Foundation of Santander (FOSCAL), Floridablanca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proa&#xf1;os</LastName><ForeName>Nadia Juliana</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>School of Medicine, Universidad de La Sabana, Ch&#xed;a, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cala-Duran</LastName><ForeName>Julian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Directorate of Research, Development and Technological Innovation, Ophthalmological Foundation of Santander (FOSCAL), Floridablanca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lora-Mantilla</LastName><ForeName>Alvaro Jose</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Directorate of Research, Development and Technological Innovation, Ophthalmological Foundation of Santander (FOSCAL), Floridablanca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>C&#xe1;ceres-Ram&#xed;rez</LastName><ForeName>Catalina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Directorate of Research, Development and Technological Innovation, Ophthalmological Foundation of Santander (FOSCAL), Floridablanca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villabona-Fl&#xf3;rez</LastName><ForeName>Silvia Juliana</ForeName><Initials>SJ</Initials><AffiliationInfo><Affiliation>Directorate of Research, Development and Technological Innovation, Ophthalmological Foundation of Santander (FOSCAL), Floridablanca, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camacho-L&#xf3;pez</LastName><ForeName>Paul Anthony</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Directorate of Research, Development and Technological Innovation, Ophthalmological Foundation of Santander (FOSCAL), Floridablanca, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">post COVID condition</Keyword><Keyword MajorTopicYN="N">post-acute sequelae of COVID-19 (PASC)</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>5</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38188329</ArticleId><ArticleId IdType="pmc">PMC10767647</ArticleId><ArticleId IdType="doi">10.3389/fmed.2023.1325616</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Worldometers . (2023). COVID &#x2013; Coronavirus Statistics &#x2013; Worldometer. Available at: https://www.worldometers.info/coronavirus/</Citation></Reference><Reference><Citation>NIH . (2023). Prioritization of Therapeutics | COVID-19 Treatment Guidelines. Available at: https://www.covid19treatmentguidelines.nih.gov/overview/prioritization-of-therapeutics/</Citation></Reference><Reference><Citation>COVID.gov . (2023). Find COVID-19 guidance for your community. Available at: https://www.covid.gov/longcovid/definitions</Citation></Reference><Reference><Citation>World Health Organization . (2021). A clinical case definition of post COVID-19 condition by a Delphi consensus. WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/20211 (Accessed December 23, 2021)</Citation></Reference><Reference><Citation>L&#xf3;pez-Sampalo A, Bernal-L&#xf3;pez MR, G&#xf3;mez-Huelgas R. S&#xed;ndrome de COVID-19 persistente. Una revisi&#xf3;n narrativa. Rev Clin Esp. (2022) 222:241&#x2013;50. doi: 10.1016/j.rce.2021.10.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2021.10.003</ArticleId><ArticleId IdType="pmc">PMC8590955</ArticleId><ArticleId IdType="pubmed">34803180</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Pallar&#xe9;s JG, Buend&#xed;a-Romero &#xc1;, Mart&#xed;nez-Cava A, Franco-L&#xf3;pez F, S&#xe1;nchez-Alcaraz Mart&#xed;nez BJ, et al. . Post-COVID-19 syndrome and the potential benefits of exercise. Int J Environ Res Public Health. (2021) 18:5329. doi: 10.3390/ijerph18105329</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18105329</ArticleId><ArticleId IdType="pmc">PMC8156194</ArticleId><ArticleId IdType="pubmed">34067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Escribano-Serranoa J, Jim&#xe9;nez-Varoa E, Casto-Jarillo C, Hormigo-Pozoc A. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India. Travel Med. Infect. Dis. (2020):102023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7955805</ArticleId><ArticleId IdType="pubmed">33727176</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike J, Kompaniyets L, Lindley MC, Saydah S, Miller G. Direct medical costs associated with post&#x2013;COVID-19 conditions among privately insured children and adults. Prev Chronic Dis. (2023) 20:E06. doi: 10.5888/pcd20.220292</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd20.220292</ArticleId><ArticleId IdType="pmc">PMC9923935</ArticleId><ArticleId IdType="pubmed">36757854</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727&#x2013;33. doi: 10.1056/NEJMoa2001017, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M, Vena A, Giacobbe DR. The novel Chinese coronavirus (2019-nCoV) infections: challenges for fighting the storm. Eur J Clin Investig. (2020) 50:1&#x2013;4. doi: 10.1111/eci.13209</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13209</ArticleId><ArticleId IdType="pmc">PMC7163647</ArticleId><ArticleId IdType="pubmed">32003000</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and Meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11:269. doi: 10.3390/pathogens11020269, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez I, Gillard J, Fragoso-Saavedra S, Feyaerts D, Islas-Weinstein L, Gallegos-Guzm&#xe1;n AA, et al. . Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study. Front Med (Lausanne). (2023) 10:1236702. doi: 10.3389/fmed.2023.1236702, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1236702</ArticleId><ArticleId IdType="pmc">PMC10505811</ArticleId><ArticleId IdType="pubmed">37727759</ArticleId></ArticleIdList></Reference><Reference><Citation>Carson G, Carson G, Sigfrid L, Olliaro P, Norton A, Paparella G, et al. . Research priorities for long Covid: refined through an international multi-stakeholder forum. BMC Med. (2021) 19:84&#x2013;4. doi: 10.1186/s12916-021-01947-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-01947-0</ArticleId><ArticleId IdType="pmc">PMC8009733</ArticleId><ArticleId IdType="pubmed">33785027</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D, Nicholson TR, Needham DM, Seylanova N, Parr C, Chen J, et al. . Studying the post-COVID-19 condition: research challenges, strategies, and importance of Core outcome set development. Christ Apfelbacher [Internet]. (2022) 20:50. doi: 10.1186/s12916-021-02222-y, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02222-y</ArticleId><ArticleId IdType="pmc">PMC8813480</ArticleId><ArticleId IdType="pubmed">35114994</ArticleId></ArticleIdList></Reference><Reference><Citation>Limesurvey GmbH . LimeSurvey: an open source survey tool /LimeSurvey GmbH, Hamburg, Germany. Available at: http://www.limesurvey.org</Citation></Reference><Reference><Citation>Ram&#xed;rez CC, Mantilla AJL, G&#xf3;mez LAP, Vargas VO, Paz MP, Esparza VF. General hospitalization and intensive care unit-related factors of COVID-19 patients in northeastern Colombia: baseline characteristics of a cohort study. Cureus. (2023) 15:e43888. doi: 10.7759/cureus.43888, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.43888</ArticleId><ArticleId IdType="pmc">PMC10515459</ArticleId><ArticleId IdType="pubmed">37746500</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosmer DW, Lemeshow S, Sturdivant RX. Applied logistic regression: 3rd Edn. John Wiley &amp; Sons: Hoboken, NJ. (2013). 1&#x2013;510.</Citation></Reference><Reference><Citation>Pazukhina E, Andreeva M, Spiridonova E, Bobkova P, Shikhaleva A, El-Taravi Y, et al. . Sechenov StopCOVID research team. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12&#x2009;months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. (2022) 20:2448. doi: 10.1186/s12916-022-02448-4, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02448-4</ArticleId><ArticleId IdType="pmc">PMC9257572</ArticleId><ArticleId IdType="pubmed">35794549</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, Lotfi M, Rostamihosseinkhani M, Nemati H, et al. . Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. (2021) 46:428&#x2013;36. doi: 10.30476/ijms.2021.92080.2326, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. (2022) 28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, Barbanotti D, Castoldi R, Mul&#xe8; G, et al. . Female sex is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect. (2022) 28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health. (2021) 17:17. doi: 10.1177/17455065211022262, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17455065211022262</ArticleId><ArticleId IdType="pmc">PMC8188967</ArticleId><ArticleId IdType="pubmed">34096383</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, Crespo M, Poveda E. Cohort COVID-19 of the Galicia Sur Health Research institute. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. (2022) 12:7414. doi: 10.1038/s41598-022-07414-x, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanne JP, Little BP, Schulte JJ, Haramati A, Haramati LB. Long-term lung abnormalities associated with COVID-19 pneumonia. Radiology. (2023) 306:e221806. doi: 10.1148/radiol.221806, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.221806</ArticleId><ArticleId IdType="pmc">PMC9462591</ArticleId><ArticleId IdType="pubmed">36040336</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves JMF, Golpe R, Garc&#xed;a-Talavera I. Enfermedad pulmonar obstructiva cr&#xf3;nica e infecci&#xf3;n por SARS-CoV-2. &#xbf;Qu&#xe9; sabemos hasta ahora? Archivos de Bronconeumolog&#xed;a. (2020) 56:5&#x2013;6. doi: 10.1016/j.arbres.2020.04.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2020.04.016</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueira Gon&#xe7;alves JM, Garc&#xed;a-Talavera I, Golpe R, Gurbani N. S&#xed;ndrome post-COVID en el paciente con enfermedad pulmonar obstructiva cr&#xf3;nica: &#xbf;un caballo de Troya? [post-COVID syndrome in the patient with chronic obstructive pulmonary disease: a Trojan horse?]. SEMERGEN. (2021) 47:136&#x2013;7. doi: 10.1016/j.semerg.2020.10.002, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semerg.2020.10.002</ArticleId><ArticleId IdType="pmc">PMC7669243</ArticleId><ArticleId IdType="pubmed">33214075</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x142;ywaczewska-Jakubowska M, Chudzik M, Babicki M, Kapusta J, Jankowski P. Lifestyle, course of COVID-19, and risk of long-COVID in non-hospitalized patients. Front Med. (2022) 9:1036556. doi: 10.3389/fmed.2022.1036556, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1036556</ArticleId><ArticleId IdType="pmc">PMC9637668</ArticleId><ArticleId IdType="pubmed">36353225</ArticleId></ArticleIdList></Reference><Reference><Citation>Boekel L, Atiqi S, Leeuw M, Hooijberg F, Besten YR, Wartena R, et al. . Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands. Lancet Rheumatol. (2023) 5:e375&#x2013;85. doi: 10.1016/S2665-9913(23)00127-3, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(23)00127-3</ArticleId><ArticleId IdType="pmc">PMC10292827</ArticleId><ArticleId IdType="pubmed">37398978</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorchenko Y, Zimba O. Long COVID in autoimmune rheumatic diseases. Rheumatol Int. (2023) 43:1197&#x2013;207. doi: 10.1007/s00296-023-05319-0, PMID:</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-023-05319-0</ArticleId><ArticleId IdType="pmc">PMC10061411</ArticleId><ArticleId IdType="pubmed">36995436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>